Bioavailability of erythromycin stearate: influence of food and fluid volume. 1978

P G Welling, and H Huang, and P F Hewitt, and L L Lyons

The influence of various test meals and coadministered water volumes on erythromycin stearate bioavailability from orally dosed film-coated tablets was studied in healthy human subjects. Serum erythromycin levels were uniformly reduced by all test meals, with the reduction in mean peak serum levels varying from 47 to 60%. Serum erythromycin levels also were reduced significantly in fasted individuals when the accompanying water volume was reduced from 250 to 20 ml. The apparent drug absorption rate constant was not influenced by treatments. This result is probably due to rapid degradation of solubilized, unabsorbed drug in the GI tract. Higher and more uniform serum erythromycin levels are obtained when erythromycin stearate tablets are given on an empty stomach together with an adequate water volume.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

P G Welling, and H Huang, and P F Hewitt, and L L Lyons
October 1979, British journal of clinical pharmacology,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
January 1981, The Journal of international medical research,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
August 1981, Antimicrobial agents and chemotherapy,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
May 1989, Clinical pharmacy,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
June 1959, The American journal of the medical sciences,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
January 1984, Pharmacology,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
January 1982, Journal of pharmaceutical sciences,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
November 1978, Journal of pharmaceutical sciences,
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
September 1953, Antibiotics & chemotherapy (Northfield, Ill.),
P G Welling, and H Huang, and P F Hewitt, and L L Lyons
January 1979, Acta pharmacologica et toxicologica,
Copied contents to your clipboard!